Medicines Patent Pool (MPP) strategy for 2023-2025. Innovative public health at its best!

The video discusses the Medicines Patent Pool (MPP) and its mission to improve access to affordable medicines in low and middle-income countries. It highlights the challenges faced by these populations, exacerbated by COVID-19, and outlines MPP's achievements since 2010. The video introduces MPP's 2023-2025 strategy, which aims to double the number of people accessing MPP-licensed products by 2025. It details five core goals, including expanding access to innovative medicines, establishing voluntary licensing for non-communicable diseases, and supporting sustainable manufacturing. The video concludes with strategies for achieving these goals and a personal reflection on MPP's impact.

What is the primary mission of the Medicines Patent Pool (MPP)?

• To limit the distribution of medicines

• To focus solely on high-income countries

• To increase the cost of medicines

• To improve access to affordable medicines

Which of the following is NOT one of MPP's core goals for 2023-2025?

• Expanding access to innovative medicines for infectious diseases

• Establishing voluntary licensing for non-communicable diseases

• Reducing the number of licensed products

• Supporting sustainable manufacturing capacity

How does MPP plan to support the development of new medical technologies?

• By reducing research funding

• By limiting access to new innovations

• By focusing only on existing technologies

• By forming strategic partnerships

What approach will MPP take to address access challenges more holistically?

• Focusing only on high-income countries

• Developing partnerships with a wider range of partners

• Limiting transparency in licensing

• Reducing the number of licensed products

What is one expected outcome of MPP's strategy by 2025?

• A decrease in the number of people accessing MPP licensed products

• An increase in the cost of medicines

• Savings of over $1.2 billion for the global community

• A reduction in the number of licensed manufacturers